Funds research to develop personalised, technology-driven strategies to reduce adverse drug reactions from multiple medications using biomarkers, AI, and data integration.
Supports AI-driven development and clinical validation of predictive biomarkers for chronic non-communicable diseases using integrated clinical and real-world data.
Funds collaborative research to develop evidence-based strategies and technologies addressing synthetic drug and stimulant challenges in Europe, supporting prevention, treatment, harm reduction, and law enforcement.
Funds early-stage clinical trials and research to develop and test innovative, multidisciplinary interventions for neurodegenerative diseases, emphasizing technology, data integration, and stakeholder engagement.
Funds research to develop new antibacterial and antifungal therapies targeting specific drug-resistant pathogens to combat antimicrobial resistance and strengthen EU health leadership.
Funding for collaborative research to develop and validate innovative healthcare interventions for major non-communicable diseases using advanced technologies and inclusive, stakeholder-driven approaches.